You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSC-100

Showing 1 - 25 of 6,961
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

Enrolling by invitation
  • Tuberous Sclerosis Complex
  • Phoenix, Arizona
  • +13 more
Jan 24, 2023

Interstitial Lung Disease Trial in Phoenix (Trans Sodium Crocetinate, Placebo)

Terminated
  • Interstitial Lung Disease
  • Trans Sodium Crocetinate
  • Placebo
  • Phoenix, Arizona
    Pulmonary Associates, P.A.
Aug 8, 2022

Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

Not yet recruiting
  • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
  • Cannabidiol Oral Solution [Epidiolex]
  • Los Angeles, California
  • +6 more
May 9, 2023

Tuberous Sclerosis Trial in United States (GNX oral suspension, TID, Placebo)

Recruiting
  • Tuberous Sclerosis
  • GNX oral suspension, TID
  • Placebo
  • Phoenix, Arizona
  • +36 more
Oct 28, 2022

Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

Active, not recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • TAVT-18 (sirolimus)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Jan 10, 2022

SARS-CoV-2 (Covid19) Trial in Bucharest (Trans Sodium Crocetinate, Normal saline)

Completed
Has Results
  • SARS-CoV-2 (Covid19)
  • Trans Sodium Crocetinate
  • Normal saline
  • Bucharest, Romania
    National Institute of Infectious Diseases- Prof. Dr. Matei Balş
Apr 12, 2022

TSC Trial in Los Angeles (JASPER)

Recruiting
  • TSC
  • JASPER
  • Los Angeles, California
    UCLA Semel Institute
Feb 1, 2022

Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)

Completed
Has Results
  • Lymphangioleiomyomatosis (LAM)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 18, 2022

Stroke, Acute Trial in Los Angeles, Charlottesville (Trans-Sodium Crocetinate, Placebo)

Terminated
Has Results
  • Stroke, Acute
  • Trans-Sodium Crocetinate
  • Placebo
  • Los Angeles, California
  • +1 more
May 24, 2021

Glioblastoma Trial in United States (Trans Sodium Crocetinate plus SOC, Standard of Care (SOC))

Terminated
Has Results
  • Glioblastoma
  • Trans Sodium Crocetinate plus SOC
  • Standard of Care (SOC)
  • Irvine, California
  • +12 more
Jul 1, 2021

TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)

Recruiting
  • TSC
  • Behavioral Symptoms
  • Behavioral Intervention in a small group platform
  • Carrboro, North Carolina
  • +1 more
Oct 23, 2023

Neurocutaneous Syndromes in Upper Egypt Children

Not yet recruiting
  • Neurocutaneous Syndromes
    • (no location specified)
    Sep 10, 2023

    B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • (no location specified)
    Aug 7, 2023

    Studies in Patients With Tuberous Sclerosis Complex

    Recruiting
    • Tuberous Sclerosis Complex
      • Phoenix, Arizona
        Translational Genomics Research Institute (TGen)
      Oct 18, 2022

      Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

      Recruiting
      • Tuberous Sclerosis
      • Lymphangioleiomyomatosis
      • Phlebotomy
      • +3 more
      • Birmingham, Alabama
      • +22 more
      Jan 6, 2023

      Tuberous Sclerosis Complex, Self-injury, Autism Trial in Baltimore (Sirolimus, Everolimus)

      Completed
      Has Results
      • Tuberous Sclerosis Complex
      • +2 more
      • Baltimore, Maryland
        Kennedy Krieger Institute
      Mar 26, 2021

      Renal Angiomyolipoma Trial (Everolimus)

      Not yet recruiting
      • Renal Angiomyolipoma
      • (no location specified)
      Aug 15, 2022

      Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

      Recruiting
      • Tuberous Sclerosis Complex
      • Basimglurant with crossover to Placebo
      • Placebo with crossover to Basimglurant
      • Phoenix, Arizona
      • +47 more
      Jan 3, 2023

      Growth and Development Trial in Belgium, Russian Federation, United States (Everolimus, Envirolimus drug class as prescribed by

      Active, not recruiting
      • Growth and Development
      • Everolimus
      • Envirolimus drug class as prescribed by Physician
      • Los Angeles, California
      • +5 more
      Dec 5, 2022

      Seizure in Participants With Tuberous Sclerosis Complex Trial in United States (GWP42003-P, SOC)

      Recruiting
      • Seizure in Participants With Tuberous Sclerosis Complex
      • Little Rock, Arkansas
      • +3 more
      Jul 6, 2022

      Healthy Volunteers With Induced Hypoxia Trial in Durham (Trans Sodium Crocetinate)

      Completed
      • Healthy Volunteers With Induced Hypoxia
      • Trans Sodium Crocetinate
      • Durham, North Carolina
        Duke University Medical Center
      Apr 12, 2022

      Tuberous Sclerosis Complex, Seizures Trial in Worldwide (GWP42003-P, Placebo)

      Completed
      Has Results
      • Tuberous Sclerosis Complex
      • Seizures
      • Birmingham, Alabama
      • +43 more
      Sep 22, 2022

      Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)

      Active, not recruiting
      • Tuberous Sclerosis Complex
      • Birmingham, Alabama
      • +12 more
      May 4, 2022

      Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Edmonton, Alberta, Canada
      • +9 more
      Jan 9, 2023